Metformin, another activator of AMPK, can inhibit the growth of esophageal squamous cell carcinomas in both cultured cells and animal models through the involvement of p53, p21, p27 and cyclinD1 [38]. The gene discussed is CCND1; the disease is esophageal squamous cell carcinoma.